Cardiometabolic criteria as predictors and treatment targets of liver-related events and cardiovascular events in metabolic dysfunction-associated steatotic liver disease,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Cardiometabolic criteria as predictors and treatment targets of liver-related events and cardiovascular events in metabolic dysfunction-associated steatotic liver disease
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-08-08 , DOI: 10.1111/apt.18205
Nobuharu Tamaki ₁ , Takefumi Kimura ₂ , Shun-Ichi Wakabayashi ₂ , Takeji Umemura ₂ , Namiki Izumi ₁ , Rohit Loomba ₃ , Masayuki Kurosaki ₁

Affiliation

The diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) requires at least one of five cardiometabolic criteria. It is unclear whether these criteria can be used as predictors and treatment targets for complications including liver-related events and major adverse cardiovascular events (MACE).

中文翻译：